The Lung Cancer Research Foundation (LCRF) announced, in collaboration with Bayer Pharmaceuticals, the recipients of two research grants focused on innovative strategies to advance the understanding and management of lung cancers harboring HER2 mutations and/or other HER2 alterations.
[Lung Cancer Research Foundation (LCRF)]